Global Biodefense | News on Pathogens and Preparedness

Menu

Editor's Picks

Transportation Isolation System (TIS)

‘TIS the Way to Transport a Highly Contagious Patient by Air

Why Ebola Vaccine on Trial in DRC is Raising Hopes

Ebola virus

Ebola Spreads to High-Risk Area of Congo

Vaccine Manufacturing - Surge Capability for Emerging Threats

New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness

Medical Countermeasure Development

BARDA Looks to Expand Clinical Studies Network for Biodefense Countermeasures

Latest Articles

in Biosecurity, Medical Countermeasures, Public Health

Why the Scientific Debate Over a UW Bird Flu Study Isn’t Going Away

Experiments Making Deadly Influenza Virus More Contagious In Mammals Are Resuming

by Will Cushman, WisContext
in Public Health

#ThisISOurLane: Gun Violence and the Role of Infectious Diseases Clinicians

by Global Biodefense
in CBRNE, Research

Long-Term Effects Following Acute Exposure to Sarin Nerve Agent
in Biosurveillance, Industry News

DHS Awards $75.2M BioWatch Contract to PAE

by Global Biodefense
in Antimicrobial Resistance, Biosecurity, Featured

‘One Health’ Keeps Humans One Step Ahead of the Microbes

by Arinjay Banerjee, Karen Mossman, and Kaushal Baid
in Biosurveillance, Emerging Threats, Pathogens

Fruit Bats in Sierra Leone Infected with Marburg Virus

by Global Biodefense
in Medical Countermeasures, Snippets + Spillover

Rethinking Ebola Vaccine Stockpile as Outbreak Threatens Mega-Cities

by Global Biodefense
in Industry News, Medical Countermeasures

Ridgeback Biotherapeutics Licenses mAb114 Ebola Treatment from NIAID

Congratulations. You've reached the end of the internet.

Back to Top

Close Add post

close